MOLECULAR CANCER THERAPEUTICS

MOLECULAR CANCER THERAPEUTICS期刊基本信息

MOLECULAR CANCER THERAPEUTICS
  • 简称:MOL CANCER THER
  • 大类:医学
  • 小类:肿瘤学
  • ISSN:1535-7163
  • IF值:4.856
  • 周期:Monthly
  • 是否SCI:SCIE
  • 是否OA:No
  • 出版地:UNITED STATES
  • 年文章数:256
  • 审稿速度:平均3月
  • 平均录用比例:约50%
投稿咨询

官方网站:http://mct.aacrjournals.org/

投稿网址:http://mct.msubmit.net/cgi-bin/main.plex

PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-7163%5BISSN%5D

MOLECULAR CANCER THERAPEUTICS中文简介

分子癌症治疗学将侧重于在以下领域对癌症治疗具有意义的基础研究:实验癌症治疗学、分子靶点的识别、化学预防靶点、新模型、癌症化学和药物发现、分子和细胞药理学、肿瘤分子分类、生物信息学和计算分子生物学。该杂志为这些新兴学科提供了一个专门关注癌症研究的出版论坛。论文经过严格审查,只有那些报告新颖、及时、有意义的研究结果并符合高科学价值标准的论文才会被接受发表。

MOLECULAR CANCER THERAPEUTICS英文简介

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

国际期刊推选 论文翻润预审发表!

选择丰富服务快速通过率高一键快速领取私人专属发表方案!

* 请认真填写需求信息,学术顾问24小时内与您取得联系。